Researchers from Hospital Clínic-IDIBAPS have led a study that has found a correlation between anti-tumour immunological activity and longevity in br1
A team from Clínic-IDIBAPS has introduced a modification to a CAR-T immunotherapy for multiple myeloma that makes it more durable, according to resul1
Chemotherapy and radiotherapy treatments have been associated with heart problems such as heart attacks and heart failure. To assess the benefits of1
Over the next three years, the chosen project, led by Roger Gomis (IRB) in consortium with Aleix Prat (Clínic-IDIBAPS), will study the factors that c1
Researchers from the Clínic-IDIBAPS have coordinated a study that analyses the efficacy of anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs) combin1
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet’s1
September 1st is World Chronic Lymphocytic Leukaemia (CLL) Day, the most common leukaemia in adults. Most patients with CLL respond well to treatment1
Els Pets, Quimi Portet, Gerard Quintana, Pemi Fortuny & Pemi Rovirosa (Lax’N’Busto), Joan Masdéu, among others, will participate in the tribute conce1
She started working at the Hospital Clínic Barcelona five years ago and has been the new head of the Gynaecology Service for three months. In recent1
A recent report from an organisation linked to the WHO states that talc is probably carcinogenic to humans. The use of talc is considered to increase1
